EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review

Yu Li, Juan Du, Guojie Ma

Int. Journal of Clinical Pharmacology and Therapeutics · 01.10.2026 · 64 (10) · 555-558

DOI: 10.5414/cp204982 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.10.2026. Verfasst von Yu Li und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Glycyrrhizic Acid, Mineralocorticoid Excess Syndrome, Apparent, Anti-Inflammatory Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycyrrhizic AcidMineralocorticoid Excess Syndrome, ApparentAnti-Inflammatory AgentsMaleHumansMiddle AgedHypokalemiaTabletsHypertension

Substanzen

Glycyrrhizic AcidTabletsAnti-Inflammatory Agents

Zitieren

APA

Li, Y., Du, J., & Ma, G. (2026). Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review. Int. Journal of Clinical Pharmacology and Therapeutics, 64(10), 555-558. https://doi.org/10.5414/cp204982

Vancouver

Li Y, Du J, Ma G. Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(10):555-558. doi:10.5414/cp204982

BibTeX
@article{Li2026,
  author = {Li, Yu and Du, Juan and Ma, Guojie},
  title = {Acquired apparent mineralocorticoid excess induced by compound glycyrrhizin tablets: A case report and literature review},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2026},
  volume = {64},
  number = {10},
  pages = {555--558},
  doi = {10.5414/cp204982}
}
Kostenlos starten →